Recap: Vanda Pharma Q2 Earnings


Vanda Pharma VNDA reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.


Vanda Pharma missed estimated earnings by 54.55%, reporting an EPS of $0.05 versus an estimate of $0.11.

Revenue was down $3.51 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 2.04% drop in the share price the next day.

Here’s a look at Vanda Pharma’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.01 0.08 0.16 0.14
EPS Actual -0.11 0.12 0.14 0.17
Revenue Estimate 58.00M 70.04M 75.00M 69.75M
Revenue Actual 60.19M 68.02M 70.09M 67.90M

To track all earnings releases for Vanda Pharma visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.


Image and article originally from Read the original article here.